After decades of leadership in pharmaceutical R&D, I’m excited to share a detailed look at my career journey—from drug discovery to biomarker development, strategic consulting, and beyond. I’ve been fortunate to work alongside exceptional teams and contribute to the development of transformative therapies. Here is my biography.

Susan Essumang is a seasoned clinical operations executive who merges scientific rigor with strategic leadership to drive high-impact pharmaceutical and biotech programs. Known for her patient-centric approach, Susan has led the development and regulatory success of globally recognized treatments, including Victoza®, Ozempic®, and Wegovy®, delivering billions in projected revenue. Her ability to align enterprise objectives with operational excellence has resulted in accelerated trial timelines, significant cost savings, and flawless regulatory inspections. With deep therapeutic expertise, a foundation in neuroscience and healthcare administration, and a commitment to innovation, Susan continues to shape the future of clinical research through data-driven insights and strategic execution.

I’m excited to share my professional journey and the expertise I’ve developed over 41 years in clinical research and drug development. As the President and Founder of New England Clinical Consulting (NECC), I’ve had the privilege of leading clinical operations across the biotech and pharma sectors, working on therapeutic areas ranging from oncology to infectious diseases. Throughout my career, I’ve tackled complex challenges, built high-performing teams, and delivered successful clinical trials from early-phase development to global Phase 3 studies. I’m passionate about advancing clinical research, overseeing CROs, and developing innovative drug development strategies. If you’re interested in clinical operations or collaborating on new projects, I’d love to connect and explore how we can work together to drive impactful results.